Annual Interest Expense
$315.30 K
+$13.70 K+4.54%
31 December 2023
Summary:
SAB Biotherapeutics annual interest expense is currently $315.30 thousand, with the most recent change of +$13.70 thousand (+4.54%) on 31 December 2023. During the last 3 years, it has fallen by -$153.90 thousand (-32.80%). SABS annual interest expense is now -32.80% below its all-time high of $469.20 thousand, reached on 31 December 2020.SABS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$78.00 K
-$15.10 K-16.22%
30 September 2024
Summary:
SAB Biotherapeutics quarterly interest expense is currently $78.00 thousand, with the most recent change of -$15.10 thousand (-16.22%) on 30 September 2024. Over the past year, it has increased by +$8300.00 (+11.91%). SABS quarterly interest expense is now -16.22% below its all-time high of $93.10 thousand, reached on 30 June 2024.SABS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$325.40 K
+$8300.00+2.62%
30 September 2024
Summary:
SAB Biotherapeutics TTM interest expense is currently $325.40 thousand, with the most recent change of +$8300.00 (+2.62%) on 30 September 2024. Over the past year, it has increased by +$300.00 (+0.09%). SABS TTM interest expense is now -0.18% below its all-time high of $326.00 thousand, reached on 30 June 2023.SABS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.5% | +11.9% | +0.1% |
| 3 y3 years | -32.8% | -0.8% | +42.6% |
| 5 y5 years | - | - | - |
SABS Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.8% | +7.1% | -16.2% | +17.6% | -0.2% | +42.6% |
| 5 y | 5 years | -32.8% | +7.1% | -16.2% | +17.6% | -0.2% | +332.7% |
| alltime | all time | -32.8% | +7.1% | -16.2% | +17.6% | -0.2% | +332.7% |
SAB Biotherapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $78.00 K(-16.2%) | $325.40 K(+2.6%) |
| June 2024 | - | $93.10 K(+21.9%) | $317.10 K(+5.9%) |
| Mar 2024 | - | $76.40 K(-1.9%) | $299.30 K(-5.1%) |
| Dec 2023 | $315.30 K(+4.5%) | $77.90 K(+11.8%) | $315.30 K(-3.0%) |
| Sept 2023 | - | $69.70 K(-7.4%) | $325.10 K(-0.3%) |
| June 2023 | - | $75.30 K(-18.5%) | $326.00 K(+1.3%) |
| Mar 2023 | - | $92.40 K(+5.4%) | $321.90 K(+6.8%) |
| Dec 2022 | $301.60 K | $87.70 K(+24.2%) | $301.50 K(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $70.60 K(-0.8%) | $280.10 K(-2.8%) |
| June 2022 | - | $71.20 K(-1.1%) | $288.10 K(-1.1%) |
| Mar 2022 | - | $72.00 K(+8.6%) | $291.30 K(-1.1%) |
| Dec 2021 | $294.50 K(-37.2%) | $66.30 K(-15.6%) | $294.50 K(+29.1%) |
| Sept 2021 | - | $78.60 K(+5.6%) | $228.20 K(+52.5%) |
| June 2021 | - | $74.40 K(-1.1%) | $149.60 K(+98.9%) |
| Mar 2021 | - | $75.20 K | $75.20 K |
| Dec 2020 | $469.20 K(+9.5%) | - | - |
| Dec 2019 | $428.50 K | - | - |
FAQ
- What is SAB Biotherapeutics annual interest expense?
- What is the all time high annual interest expense for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual interest expense year-on-year change?
- What is SAB Biotherapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly interest expense year-on-year change?
- What is SAB Biotherapeutics TTM interest expense?
- What is the all time high TTM interest expense for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM interest expense year-on-year change?
What is SAB Biotherapeutics annual interest expense?
The current annual interest expense of SABS is $315.30 K
What is the all time high annual interest expense for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual interest expense is $469.20 K
What is SAB Biotherapeutics annual interest expense year-on-year change?
Over the past year, SABS annual interest expense has changed by +$13.70 K (+4.54%)
What is SAB Biotherapeutics quarterly interest expense?
The current quarterly interest expense of SABS is $78.00 K
What is the all time high quarterly interest expense for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly interest expense is $93.10 K
What is SAB Biotherapeutics quarterly interest expense year-on-year change?
Over the past year, SABS quarterly interest expense has changed by +$8300.00 (+11.91%)
What is SAB Biotherapeutics TTM interest expense?
The current TTM interest expense of SABS is $325.40 K
What is the all time high TTM interest expense for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM interest expense is $326.00 K
What is SAB Biotherapeutics TTM interest expense year-on-year change?
Over the past year, SABS TTM interest expense has changed by +$300.00 (+0.09%)